Results for EPO Boards of Appeal
EPO pharma case law trends 2025: Clinical inventions EPO pharma case law trends 2025: Clinical inventions Reviewed by Dr Rose Hughes on Monday, November 24, 2025 Rating: 5
EPO pharma case law trends 2025: Antibodies and biologics EPO pharma case law trends 2025: Antibodies and biologics Reviewed by Dr Rose Hughes on Monday, November 17, 2025 Rating: 5
Never Too Late: If you missed the IPKat last week! Never Too Late: If you missed the IPKat last week! Reviewed by Asude Sena Moya on Tuesday, March 25, 2025 Rating: 5
Excluding a technical feature is not inventive without evidence of a technical effect (T 1865/22) Excluding a technical feature is not inventive without evidence of a technical effect (T 1865/22) Reviewed by Dr Rose Hughes on Friday, March 21, 2025 Rating: 5
Functional claims for pharmaceutical formulations: Validity versus enforcement (T 2130/22) Functional claims for pharmaceutical formulations: Validity versus enforcement (T 2130/22) Reviewed by Dr Rose Hughes on Friday, January 24, 2025 Rating: 5
The morality (and patentability) of inventions derived by immoral means (T 2510/18) The morality (and patentability) of inventions derived by immoral means (T 2510/18) Reviewed by Dr Rose Hughes on Thursday, October 31, 2024 Rating: 5
Stretching the cheese: Contradictory evidence for a purported technical effect relied on for inventive step (T 0629/22) Stretching the cheese: Contradictory evidence for a purported technical effect relied on for inventive step (T 0629/22) Reviewed by Dr Rose Hughes on Monday, May 13, 2024 Rating: 5
Powered by Blogger.